Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies.
Transfus Apher Sci
; 59(5): 102839, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: covidwho-506054
ABSTRACT
COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Transfusión de Componentes Sanguíneos
/
COVID-19
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Transfus Apher Sci
Asunto de la revista:
Hematología
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
J.transci.2020.102839
Similares
MEDLINE
...
LILACS
LIS